53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers
Author(s) -
Peter Bouwman,
Amal Aly,
José Miguel Escandell,
Mark Pieterse,
Jiřina Bártková,
Hanneke van der Gulden,
Sanne Hiddingh,
Maria Thanasoula,
Atul Kulkarni,
Qifeng Yang,
Bruce G. Haffty,
Johanna Tommiska,
Carl Blomqvist,
Ronny Drapkin,
David J. Adams,
Heli Nevanlinna,
Jiří Bártek,
Madalena Tarsounas,
Shridar Ganesan,
Jos Jonkers
Publication year - 2010
Publication title -
nature structural and molecular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 9.448
H-Index - 270
eISSN - 1545-9993
pISSN - 1545-9985
DOI - 10.1038/nsmb.1831
Subject(s) - cancer research , genome instability , homologous recombination , dna damage , brca2 protein , cell cycle checkpoint , biology , mutation , dna repair , chek1 , breast cancer , triple negative breast cancer , g2 m dna damage checkpoint , poly adp ribose polymerase , cell cycle , microbiology and biotechnology , germline mutation , cancer , genetics , dna , gene , polymerase
Germ-line mutations in breast cancer 1, early onset (BRCA1) result in predisposition to breast and ovarian cancer. BRCA1-mutated tumors show genomic instability, mainly as a consequence of impaired recombinatorial DNA repair. Here we identify p53-binding protein 1 (53BP1) as an essential factor for sustaining the growth arrest induced by Brca1 deletion. Depletion of 53BP1 abrogates the ATM-dependent checkpoint response and G2 cell-cycle arrest triggered by the accumulation of DNA breaks in Brca1-deleted cells. This effect of 53BP1 is specific to BRCA1 function, as 53BP1 depletion did not alleviate proliferation arrest or checkpoint responses in Brca2-deleted cells. Notably, loss of 53BP1 partially restores the homologous-recombination defect of Brca1-deleted cells and reverts their hypersensitivity to DNA-damaging agents. We find reduced 53BP1 expression in subsets of sporadic triple-negative and BRCA-associated breast cancers, indicating the potential clinical implications of our findings.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom